DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,566,218 | +430.5% | 851,489 | +658.8% | 0.21% | +428.2% |
| Q2 2023 | $3,311,376 | +43.3% | 112,212 | +11.9% | 0.04% | +25.8% |
| Q1 2023 | $2,311,165 | -83.0% | 100,311 | -77.4% | 0.03% | -83.8% |
| Q3 2022 | $13,634,000 | +156.0% | 444,256 | +145.5% | 0.19% | +132.9% |
| Q2 2022 | $5,326,000 | -35.5% | 180,972 | -29.5% | 0.08% | -38.8% |
| Q1 2022 | $8,257,000 | +253.0% | 256,678 | +389.3% | 0.13% | +294.1% |
| Q4 2021 | $2,339,000 | – | 52,454 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |